<p>Stably-transfected uPAR-293 cells (<b>A, C, E</b>) or V-293 cells (<b>B, D, F</b>) were pre-incubated with nonimmune Ig (<b>-</b>) or anti-uPAR or anti-uPAR<sub>84–95</sub> polyclonal antibodies (<b>A and B</b>), with diluents (-) or P-25 or W (W Pep) peptides (<b>C and D</b>), with diluents (-) or inhibitors of Rho- or Rac1-dependent signaling pathways (<b>E and F, left panels</b>), with diluents (-) or inhibitors of PI3K or ERK-MAPKs (<b>E and F, right panels</b>). Cells were then plated in Boyden chambers and allowed to migrate toward 100 ng/ml EGF. Migrated cells were fixed, stained with hematoxylin, and counted; results are expressed as percentage of cells migrated towards EGF over the cells migrated without EGF; 100% values represe...
<p><b>(A)</b> Increase in migration over basal levels of metastatic and non-metastatic OS cells in t...
<p>Migration activity of AGS cells was analyzed with transwell system. The cells were infected with ...
<p><b>(A)</b> Migration of KHOS WT and KHOS uPAR-KD in the absence (control) or presence of 100 nM u...
<p>uPAR-293 cells (<b>A and C</b>) or V-293 cells (<b>B and D</b>) were pre-incubated with diluents ...
<p>uPAR-293 cells (<b>A</b>) or V-293 cells (<b>B</b>) were pre-incubated with nonimmune immunoglobu...
<p>uPAR-293 and V-293 cells efficiently migrate toward serum growth factors or EGF (GF). However, uP...
<p><b>A:</b> Prostate carcinoma (PC3) cells were transfected with a uPAR-targeting siRNA or a non-ta...
Objectives. The EGFR is expressed in malignant ovarian tumor tissue, and tissue content of EGFR has ...
<p>uPAR-293 cells (<b>A and C</b>) or V-293 cells (<b>B and D</b>) were pre-incubated with diluent (...
The urokinase (uPA) receptor (uPAR) plays a key role in cell migration. We previously showed that uP...
Cell migration is the first step of the invasive process, which is part of the malignant phenotype, ...
Urokinase-type plasminogen activator (uPA) binding to uPAR induces migration, adhesion, and prolifer...
The receptor (uPAR) of the urokinase-type plasminogen activator (uPA) is crucial in cell migration s...
The receptor (uPAR) of the urokinase-type plasminogen activator (uPA) is crucial in cell migration s...
In glioblastoma (GBM), the EGF receptor (EGFR) and Src family kinases (SFKs) contribute to an aggres...
<p><b>(A)</b> Increase in migration over basal levels of metastatic and non-metastatic OS cells in t...
<p>Migration activity of AGS cells was analyzed with transwell system. The cells were infected with ...
<p><b>(A)</b> Migration of KHOS WT and KHOS uPAR-KD in the absence (control) or presence of 100 nM u...
<p>uPAR-293 cells (<b>A and C</b>) or V-293 cells (<b>B and D</b>) were pre-incubated with diluents ...
<p>uPAR-293 cells (<b>A</b>) or V-293 cells (<b>B</b>) were pre-incubated with nonimmune immunoglobu...
<p>uPAR-293 and V-293 cells efficiently migrate toward serum growth factors or EGF (GF). However, uP...
<p><b>A:</b> Prostate carcinoma (PC3) cells were transfected with a uPAR-targeting siRNA or a non-ta...
Objectives. The EGFR is expressed in malignant ovarian tumor tissue, and tissue content of EGFR has ...
<p>uPAR-293 cells (<b>A and C</b>) or V-293 cells (<b>B and D</b>) were pre-incubated with diluent (...
The urokinase (uPA) receptor (uPAR) plays a key role in cell migration. We previously showed that uP...
Cell migration is the first step of the invasive process, which is part of the malignant phenotype, ...
Urokinase-type plasminogen activator (uPA) binding to uPAR induces migration, adhesion, and prolifer...
The receptor (uPAR) of the urokinase-type plasminogen activator (uPA) is crucial in cell migration s...
The receptor (uPAR) of the urokinase-type plasminogen activator (uPA) is crucial in cell migration s...
In glioblastoma (GBM), the EGF receptor (EGFR) and Src family kinases (SFKs) contribute to an aggres...
<p><b>(A)</b> Increase in migration over basal levels of metastatic and non-metastatic OS cells in t...
<p>Migration activity of AGS cells was analyzed with transwell system. The cells were infected with ...
<p><b>(A)</b> Migration of KHOS WT and KHOS uPAR-KD in the absence (control) or presence of 100 nM u...